comparemela.com

Latest Breaking News On - Athira pharma inc - Page 4 : comparemela.com

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting

Presentation to highlight therapeutic potential of Athira’s small molecules targeting the neurotrophic HGF system in neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s.

United statesAthira pharmaJanine bogrisKevin churchSecurities exchangeAmerican academy of neurologyAthira pharma incExchange commissionAmerican academyTargeting neurotrophicPoster sessionGeneral neurologyChief scientific officerScientific publicationsSecurities actSecurities exchange act

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesMark littonSharay settiHans moebiusRachel leningtonSherif redaAthira pharmaJulie rathbunAlzheimer association international congressMotor neurone disease associationSociety for neuroscience sfn annual meetingSecurities exchangeInternational symposiumExchange commissionClinical development pipeline programsDevelopment rd expenses

Short Interest in Athira Pharma, Inc (NASDAQ:ATHA) Grows By 39 6%

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 717,600 shares, an increase of 39.6% from the January 15th total of 513,900 shares. Based on an average daily volume of 331,300 shares, the short-interest ratio […]

Athira pharmaJacobs levy equity management incRenaissance technologiesDimensional fund advisorsAthira pharma company profilePerceptive advisors llcAthira pharma incGet free reportDirector perceptive advisors llcFund advisorsLevy equity managementSigma advisersAthira pharma dailyNasdaq atha

Century Therapeutics (NASDAQ:IPSC) & Athira Pharma (NASDAQ:ATHA) Financial Survey

Century Therapeutics (NASDAQ:IPSC – Get Free Report) and Athira Pharma (NASDAQ:ATHA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk. Valuation and Earnings This table compares Century […]

United statesWashington state universityAthira pharmaAthira pharma incCentury therapeutics incNational institutes of health grantBiotechnology incCentury therapeuticsGet free reportGiven athira pharmaAmyotrophic lateralNational institutesHealth grantCentury therapeutics dailyNasdaq ipscStock comparison

Athira Pharma s ATH-1105 Shows Promise for ALS in Neuroscience Study

Athira Pharma s ATH-1105 Shows Promise for ALS in Neuroscience Study
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Mark littonAthira pharma incKevin churchAthira pharmaChief scientific officerChief executive officerScientific publications

vimarsana © 2020. All Rights Reserved.